Skip to main content
Market intelligence
ONCSector not reported

BeOne Medicines Ltd. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 12, 2026John OylerChief Executive OfficerSale240,810$359.12$86,480,482
Aug 11, 2026Chan Henry LeeSVP, General CounselSale2,666$360.00$959,760
Aug 3, 2026Aaron RosenbergChief Financial OfficerSale1,157$312.72$361,811